Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true?

Hepatology. 2022 Aug;76(2):300-302. doi: 10.1002/hep.32445. Epub 2022 Mar 19.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aspirin / therapeutic use
  • Carcinoma, Hepatocellular* / etiology
  • Carcinoma, Hepatocellular* / prevention & control
  • Hepatitis B virus
  • Humans
  • Liver Cirrhosis
  • Liver Neoplasms* / etiology
  • Liver Neoplasms* / prevention & control
  • Risk Factors

Substances

  • Aspirin